Lymphadenitis

Summary

Lymphadenitis (MONDO:0002052) is a disease (an umbrella term covering 10 Mondo subtypes) and 4 clinical trials. A subtype of lymph node disorder — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Umbrella term: 10 Mondo subtypes
• Clinical trials: 4

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	lymphadenitis
Mondo ID	MONDO:0002052
MeSH	D008199
DOID	DOID:1602
ICD-11	1483611415
NCIT	C26821
SNOMED CT	41174002
UMLS	C0024205
MedGen	7410
Is cancer (heuristic)	no

Also known as: acute adenitis · acute lymphadenitis · adenitis · chronic adenitis · chronic lymphadenitis · lymph node inflammation · lymph nodeitis · lymphadenitis · lymphadenitis (disease)

Data availability: 1 HPO phenotype · 1 cell line.

Disease family

This is a subtype of lymph node disorder. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › immune system disorder › lymphoid system disorder › lymphatic system disorder › lymph node disorder › lymphadenitis

Related subtypes (3): glandular tularemia, lymph node tuberculosis, lymph node neoplasm

Subtypes (10): mesenteric lymphadenitis, cervical lymphadenitis, postauricular lymphadenitis, suppurative lymphadenitis, axillary lymphadenitis, cat-scratch disease, sialadenitis, Kawasaki disease, Kimura disease, Kikuchi-Fujimoto disease

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 4.

Phase distribution (across all retrieved trials)

Phase	Trials
Not specified	3
PHASE4	1

Top trials by phase / activity

NCT	Phase	Status	Title
NCT07532941	PHASE4	NOT_YET_RECRUITING	Clinical Efficacy of Stopping Oral Antibiotics When Symptoms Stop, Compared to ‘Finishing the Course’
NCT06023550	Not specified	RECRUITING	Complicated Infections in Otorhinolaryngology
NCT00172445	Not specified	WITHDRAWN	Clinical Studies of Kikuchi’s Disease
NCT01383226	Not specified	COMPLETED	Linear Endosonography for the Assessment of Sarcoidosis Stage O